BuDb: A Curated Drug Discovery Database for Buruli Ulcer

2Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Buruli ulcer (BU), a severe skin disease is caused by Mycobacterium ulcerans. There are concerns of therapeutic inefficacy of existing drugs coupled with chemoresistance. Databases have been shown to augment data mining and integrative systems pharmacology approaches towards the search for novel therapeutic moieties. So far, there is no known integrated database solely dedicated to BU drug discovery. In this work, Buruli ulcer database (BuDb) is a "one-stop-shop"knowledgebase for supporting BU drug discovery. It contains both manually verified literature and database-curated data on BU. The BuDb provides comprehensive information on the various drug targets, tested compounds, existing drugs, ethnopharmacological plants and information on the genome of M. ulcerans. It also contains cross-referenced links to databases including PubMed, PubChem, DrugBank, NCBI, Gene Ontology (GO), UniProt, Prota4u, String database, KEGG Pathway and KEGG genome database. The BuDb has been implemented with accessibility features such as keyword and specific searches as well as browsing. BuDb is the first useful online repository of its kind integrated with enriched datasets that can aid in the discovery of new biotherapeutic entities for BU.

Cite

CITATION STYLE

APA

Kwofie, S. K., Anyimadu, D. T., Aryee, S., Asare, B., Kokroko, N., Owusu, J. A., … Wilson, M. D. (2023). BuDb: A Curated Drug Discovery Database for Buruli Ulcer. Journal of Computational Biophysics and Chemistry, 22(1), 31–41. https://doi.org/10.1142/S2737416523500011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free